X

pharmaceuticals

Trxade Health Inc. (NASDAQ: MEDS) Q2 2021 Research Summary

Trxade Health Inc. (NASDAQ: MEDS), a health services IT company, plays a key role in ensuring the availability of healthcare…

Is Merck (MRK) stock still a buy after losing the vaccine race?

After bringing the global economy to a grinding halt, the coronavirus pandemic is subsiding in most regions, thanks to the…

LLY Stock: Is Eli Lilly a good bet in COVID-challenged healthcare market?

For pharmaceutical companies, 2020 was a busy year when the healthcare sector went into overdrive to deal with the challenges…

SmileDirectClub (SDC) bets on rapid telemedicine-adoption to drive growth

The adoption of telemedicine accelerated in recent months, especially after the pandemic-related shelter-in-place orders came into effect. The trend will…

SmileDirectClub (SDC) Q1 Report: Net loss narrows but misses estimates

Digital healthcare firm SmileDirectClub Inc. (NASDAQ: SDC) reported a narrower net loss for the first quarter of 2021 amid modest…

Pfizer, Inc. (PFE) Q1 2021 Earnings Call Transcript

Pfizer, Inc. (NYSE: PFE) Q1 2021 earnings call dated May. 04, 2021 Corporate Participants: Charles E. Triano -- Senior Vice President, Investor…

Pfizer (PFE) reports Q1 EPS of 93 cents: Infographic

Pfizer (NYSE: PFE) reported first-quarter 2021 financial results ahead of the regular market hours on Tuesday. The pharmaceutical giant reported…

AbbVie (ABBV) Stock: Here’s what you need to know before investing

AbbVie Inc. (NYSE: ABBV) has long been fighting to delay the entry of generic alternatives to Humira, the pharma giant's…

Vertex Pharmaceuticals Inc (VRTX) Q1 2021 Earnings Call Transcript

Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Michael Partridge -- Senior Vice President of…

Vertex Pharmaceuticals reports 14% growth in Q1 revenue: Infographic

Vertex Pharmaceuticals (NASDAQ: VRTX) reported first-quarter 2021 financial results after the regular market hours on Thursday. The pharmaceutical firm reported…

Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results

Teva Pharmaceuticals’ (NYSE: TEVA) reported first-quarter 2021 results today before the opening bell. The company dropped its revenue by 9%…

Johnson & Johnson (JNJ) reports Q1 2021 earnings

Johnson & Johnson (NYSE: JNJ) reported first-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant…

Two areas that provide Pfizer (PFE) with ample opportunity for future growth

Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past one year. Pfizer is at the forefront…

It’s worth keeping an eye on Vertex Pharma (VRTX) stock. Here’s why

After dominating the cystic fibrosis market for quite some time, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is currently expanding its clinical…

Will restructuring, cost-cutting help Walgreens (WBA) beat COVID blues?

The growing demand for new therapeutic solutions and advanced research in areas like human-genome will keep the biotechnology industry busy…

Walgreens Boots Alliance Inc. (WBA) Q2 2021 Earnings Call

Walgreens Boots Alliance Inc. (NASDAQ: WBA) Q2 2021 earnings call dated Mar. 31, 2021 Corporate Participants: Gerald Gradwell — Senior Vice President of…

Here’s what you need to know before investing in Amgen (AMGN)

The coronavirus outbreak has made leading pharma companies channelize their resources for vaccine development, and the efforts have been largely…

Walgreens Boots Alliance, Inc. (WBA) Q2 2021 Earnings Call Transcript

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q2 2021 earnings call dated Mar. 31, 2021 Corporate Participants: Gerald Gradwell -- Senior Vice President…

Walgreens Boots Alliance (WBA) Earnings: Key financials and quarterly highlights

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported second-quarter 2021 earnings results today. Sales increased 4.6% to $32.8 billion. It is…

What’s happening on the COVID-19 front? Here are a few updates.

Right about this time last year, the COVID-19 pandemic took over the world with full force as several countries went…

These two factors will play out in favor of Pfizer (PFE) going forward

Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past 12 months. The company had a huge…